NEUROVIRUSES COMPREHENSIVE PANEL QUALITATIVE PCR Test
Test Name: NEUROVIRUSES COMPREHENSIVE PANEL QUALITATIVE PCR Test
Components:
- Adenovirus
- Cytomegalovirus
- Enteroviruses
- Epstein Barr virus
- Herpes simplex virus 1 & 2
- Varicella Zoster virus
- Parechoviruses
- HHV6
- HHV7
- Parvovirus B19
- Japanese Encephalitis virus
Price: 1760.0 AED
Sample Condition: 3 mL (2 mL min.) CSF in a sterile screw capped container. Ship refrigerated or frozen.
Report Delivery: Sample Thu by 11 am; Report Sat
Method: Real Time PCR
Test Type: Disorders of Nervous System
Doctor: Neurologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: No special preparation required
Test Details
The Neuroviruses Comprehensive Panel Qualitative PCR test is a diagnostic test used to detect the presence of neuroviruses in a patient’s sample. Neuroviruses are a group of viruses that can infect the nervous system and cause various neurological symptoms.
The test utilizes a technique called polymerase chain reaction (PCR), which amplifies the genetic material of the viruses present in the sample. This allows for the detection and identification of specific neuroviruses, such as herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), and others.
The Neuroviruses Comprehensive Panel Qualitative PCR test can help healthcare providers diagnose viral infections that affect the nervous system and guide appropriate treatment. It is particularly useful for patients with symptoms such as meningitis, encephalitis, myelitis, or other neurological manifestations.
During the test, a sample is collected from the patient, typically through a swab of the affected area or by obtaining cerebrospinal fluid (CSF) through a lumbar puncture. The sample is then sent to a laboratory where it undergoes PCR analysis to detect the presence of neuroviruses.
The test results will indicate whether any of the targeted neuroviruses are present in the patient’s sample. A positive result suggests an active infection, while a negative result indicates the absence of the tested neuroviruses.
It is important to note that the Neuroviruses Comprehensive Panel Qualitative PCR test only detects the presence of specific neuroviruses included in the panel. It does not provide information about other possible causes of neurological symptoms or infections caused by non-targeted viruses.
Overall, the Neuroviruses Comprehensive Panel Qualitative PCR test is a valuable tool in diagnosing neuroviral infections and guiding appropriate treatment decisions. It helps healthcare providers identify the specific virus causing neurological symptoms, allowing for targeted therapy and better patient management.
| Test Name | NEUROVIRUSES COMPREHENSIVE PANEL QUALITATIVE PCR Test |
|---|---|
| Components | *Adenovirus*Cytomegalovirus*Enteroviruses*Epstein Barr virus*Herpes simplex virus 1 & 2*Varicella Zoster virus *Parechoviruses*HHV6*HHV7*Parvovirus B19*Japanese Encephalitis virus |
| Price | 1760.0 AED |
| Sample Condition | 3 mL (2 mL min.) CSF in a sterile screw capped container. Ship refrigerated or frozen. |
| Report Delivery | Sample Thu by 11 am; Report Sat |
| Method | Real Time PCR |
| Test type | Disorders of Nervous System |
| Doctor | Neurologist |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | No special preparation required |
| Test Details |
The Neuroviruses Comprehensive Panel Qualitative PCR test is a diagnostic test used to detect the presence of neuroviruses in a patient’s sample. Neuroviruses are a group of viruses that can infect the nervous system and cause various neurological symptoms. The test utilizes a technique called polymerase chain reaction (PCR), which amplifies the genetic material of the viruses present in the sample. This allows for the detection and identification of specific neuroviruses, such as herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), and others. The Neuroviruses Comprehensive Panel Qualitative PCR test can help healthcare providers diagnose viral infections that affect the nervous system and guide appropriate treatment. It is particularly useful for patients with symptoms such as meningitis, encephalitis, myelitis, or other neurological manifestations. During the test, a sample is collected from the patient, typically through a swab of the affected area or by obtaining cerebrospinal fluid (CSF) through a lumbar puncture. The sample is then sent to a laboratory where it undergoes PCR analysis to detect the presence of neuroviruses. The test results will indicate whether any of the targeted neuroviruses are present in the patient’s sample. A positive result suggests an active infection, while a negative result indicates the absence of the tested neuroviruses. It is important to note that the Neuroviruses Comprehensive Panel Qualitative PCR test only detects the presence of specific neuroviruses included in the panel. It does not provide information about other possible causes of neurological symptoms or infections caused by non-targeted viruses. Overall, the Neuroviruses Comprehensive Panel Qualitative PCR test is a valuable tool in diagnosing neuroviral infections and guiding appropriate treatment decisions. It helps healthcare providers identify the specific virus causing neurological symptoms, allowing for targeted therapy and better patient management. |
